Date: 2011-07-14
Type of information: Fundraising
Company: Lophius Biosciences (Germany)
Investors: All current financial investors of the company
Amount: €1.4 Million
Funding type: financing round
Planned used: The funds will be used for the market introduction of the T-Track© CMV/EBV tests in the field of transplantation, for further development of a diagnostic test for the differential diagnosis of tuberculosis, as well as for the new development of a novel, blood-based multiple sclerosis test.
Others: Lophius Biosciences has announced closing of an additional financing round totaling 1.4 million EUR. All current financial investors, such as S-Refit, High-Tech Gründerfonds (HTGF) as well as Bayernkapital participated in this financing round.
Therapeutic area: Translantation - Infectious diseases
